Uganda began to start studying the ebola vaccine

Health officials in Uganda are preparing to implement a judgment vaccine as part of the efforts to stop an ebola in the capital, Kampala.

A number of scientists develop research protocols on the planned conduct of over 2,000 doses of candidate vaccine against Sudan de Ebola, said Pontiano Kaleebu, executive director of the Uganda Virus Institute (UVRI).

The “protocol is accelerated” to obtain all the necessary regulatory approvals, he said. “This vaccine is not yet licensed.”

The World Health Organization (WHO) has stated in a statement that its support for the response of Uganda to the outbreak includes access to 2,160 doses of judgment.

“The research teams were carried out on the field to work with the surveillance teams, while the approvals are expected,” said a WHO statement.

The candidate vaccine, as well as the candidate treatments are made available by clinical study protocols to continue to test effectiveness and safety, he said.

The vaccine manufacturer was not known immediately. There are no approved vaccines for the Sudan stem in Ebola who killed an assistant employed at the main referral hospital in Kampala. The man died on Wednesday, and the authorities declared a outbreak the next day.

The officials still investigate the outbreak source and there was no other confirmed case. Uganda had access to the doses of candidate vaccines from the end of an Ebola outbreak in September 2022, which killed at least 55 people. Uganda officials were left without time to start a vaccine study when that outbreak, in the center of Uganda, was declared in four months later, Kaleebu said.

A study vaccine known as RVSV-Zebov, used to vaccinate 3,000 people at risk during an outbreak of the Ebola stalk in East Congo between 2018 and 2020, has been effectively proven to contain the spread of the disease there.

Uganda had several foci outbreaks, including one in 2000 who killed hundreds. The Ebola focus 2014-16 in Western Africa killed over 11,000 people, the largest death death.

The tracking of contacts is also essential to create the spread of the ebola, which manifests itself as a viral hemorrhagic fever. At least 44 victim’s contacts were identified in the current outbreak, including 30 health workers and patients, according to the Ministry of Health in Uganda.

Ebola confirmation in Uganda is the most recent in a series of viral hemorrhagic fever outbreaks in the Eastern -African region. Tanzania declared an outbreak of Marburg’s disease similar to Ebola earlier this month, while in December, Rwanda announced that her own outbreak of Marburg ended.

The outbreak under Marburg in the Kagera region of northern Tanzania killed at least two people, according to local health authorities. Kampala’s outbreak could prove difficult to answer, because the city has an extremely mobile population of about 4 million.

The assistant who died sought treatment at a hospital right outside Kampala and later traveled to Mbale, to the east of the country, where he was admitted to a public hospital. The health authorities have said that the man also sought the services of a traditional healer.

The eBola is spread by contact with the bodily liquids of an infected person or contaminated materials. Symptoms include fever, vomiting, diarrhea, muscle pain and sometimes internal and external bleeding.

Scientists do not know the natural tank of Ebola, but suspect that the first person infected in a outbreak has acquired the virus by contact with an infected animal or eating raw meat.

The Ebola was discovered in 1976 in two simultaneous outbreaks in the South Sudan and Congo, where it took place in a village near the Ebola river, after which the disease is called.